[go: up one dir, main page]

SK495A3 - Detection method of antibodies of hepatitis virus and set for detection of antibodies hcv - Google Patents

Detection method of antibodies of hepatitis virus and set for detection of antibodies hcv

Info

Publication number
SK495A3
SK495A3 SK4-95A SK495A SK495A3 SK 495 A3 SK495 A3 SK 495A3 SK 495 A SK495 A SK 495A SK 495 A3 SK495 A3 SK 495A3
Authority
SK
Slovakia
Prior art keywords
antibodies
hcv
antigens
detection
conformational epitopes
Prior art date
Application number
SK4-95A
Other languages
Slovak (sk)
Other versions
SK284556B6 (en
Inventor
David Y Chien
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25429280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK495(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of SK495A3 publication Critical patent/SK495A3/en
Publication of SK284556B6 publication Critical patent/SK284556B6/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Immunoassay methods utilizing HCV envelope antigens that contain conformational epitopes reactive with antibodies in serum from infected individuals are useful for screening and diagnosis. These antigens detect antibodies that are not detected by denatured HCV envelope antigens. In addition, these HCV envelope antigens comprised of conformational epitopes are more immunologically reactive than a number of other HCV antigens. This is the first evidence that conformational epitopes may be involved in the immunologic response to HCV antigens.
SK4-95A 1992-07-07 1993-07-02 A method for detecting early seroconversion with hepatitis C virus and a kit for use in the method SK284556B6 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91075992A 1992-07-07 1992-07-07
PCT/US1993/006309 WO1994001778A1 (en) 1992-07-07 1993-07-02 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes

Publications (2)

Publication Number Publication Date
SK495A3 true SK495A3 (en) 1995-07-11
SK284556B6 SK284556B6 (en) 2005-06-02

Family

ID=25429280

Family Applications (1)

Application Number Title Priority Date Filing Date
SK4-95A SK284556B6 (en) 1992-07-07 1993-07-02 A method for detecting early seroconversion with hepatitis C virus and a kit for use in the method

Country Status (19)

Country Link
US (1) US20020150883A1 (en)
EP (1) EP0649537B2 (en)
JP (2) JP3490085B2 (en)
AT (1) ATE216779T1 (en)
AU (1) AU685059B2 (en)
CA (1) CA2139645C (en)
CZ (1) CZ291951B6 (en)
DE (1) DE69331845T3 (en)
DK (1) DK0649537T4 (en)
ES (1) ES2171414T5 (en)
FI (1) FI110546B (en)
HU (1) HUT70473A (en)
NO (1) NO321185B1 (en)
PL (1) PL174686B1 (en)
PT (1) PT649537E (en)
RU (1) RU2126158C1 (en)
SK (1) SK284556B6 (en)
UA (1) UA39944C2 (en)
WO (1) WO1994001778A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
EP0721505B2 (en) 1994-07-29 2006-05-10 Innogenetics N.V. Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
DE4428705A1 (en) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Recombinant antigen from the NS3 region of the hepatitis C virus
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
EP0836708A1 (en) * 1995-06-07 1998-04-22 Abbott Laboratories Method for antibody to hepatitis c virus second envelope glycoprotein
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
WO2000026673A1 (en) * 1998-11-03 2000-05-11 Abbott Laboratories Methods of detecting chronic infection caused by hcv
WO2001009609A2 (en) * 1999-07-28 2001-02-08 Chiron Corporation Hepatitis c viral antigen immunoassay detection systems
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
EP1829891B1 (en) 2000-06-15 2012-12-26 Novartis Vaccines and Diagnostics, Inc. Immunoassays for Anti-HCV Antibodies
DE60129598T2 (en) 2000-06-15 2008-04-17 Novartis Vaccines and Diagnostics, Inc., Emeryville Immunoassays for anti-HCV antibodies
AR045702A1 (en) 2001-10-03 2005-11-09 Chiron Corp COMPOSITIONS OF ASSISTANTS.
US7166426B2 (en) 2002-09-09 2007-01-23 Novartis Vaccines And Diagnostics, Inc. HCV assay
WO2004071414A2 (en) * 2003-02-05 2004-08-26 Genzyme Corporation Therapeutic anti-hcv (al9) compounds
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
ATE542140T1 (en) 2004-08-27 2012-02-15 Novartis Vaccines & Diagnostic NON-STRUCTURAL HCV PROTEIN MUTANTS AND POSSIBLE USES THEREOF
WO2008024518A2 (en) 2006-08-25 2008-02-28 Novartis Ag Hcv fusion polypeptides
ES2664753T3 (en) 2007-12-07 2018-04-23 Glaxosmithkline Biologicals Sa Immune response induction compositions
FR2984328B1 (en) 2011-12-20 2016-12-30 Bio-Rad Innovations METHOD FOR DETECTING HEPATITIS C VIRUS INFECTION
CA2906407A1 (en) 2013-03-14 2014-09-18 Abbott Laboratories Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
US9194873B2 (en) 2013-03-14 2015-11-24 Abbott Laboratories HCV antigen-antibody combination assay and methods and compositions for use therein
WO2014143343A1 (en) 2013-03-14 2014-09-18 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
WO2016160046A1 (en) 2015-03-27 2016-10-06 Ortho-Clinical Diagnostics, Inc. Hcv ns4a/modified ns3 polypeptides and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
NZ227011A (en) 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
JP2656995B2 (en) 1989-03-17 1997-09-24 カイロン コーポレイション NANBV diagnostics
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
FI906208L (en) * 1989-12-18 1991-06-19 Wellcome Found OFFICIALLY YESTERDAY.
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
HU217025B (en) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C virus (HCV) antigen preparations for detecting anti-HCV antibodies in immunoassays
KR100217483B1 (en) * 1990-04-06 1999-09-01 프랭크 쿵 Hepatitis C Virus Epitope
NZ238681A (en) * 1990-06-25 1992-03-26 Univ Osaka Res Found Non-a, non-b hepatitis virus particles and their production
EP0468657A3 (en) * 1990-07-09 1992-02-05 Tonen Corporation Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
DK0842947T4 (en) * 1990-11-08 2009-06-08 Novartis Vaccines & Diagnostic Hepatitis C virus asialoglycoproteins
IT1249684B (en) * 1991-07-19 1995-03-09 Sorin Biomedica Spa HEPATITIS VIRUS PROTEIN ENV EPITOPES
DE69333269T2 (en) * 1992-01-31 2004-07-29 Abbott Laboratories, Abbott Park EXPRESSION SYSTEM IN MAMMALS FOR HCV PROTEINS
US5587285A (en) * 1992-01-31 1996-12-24 University Of Texas System Generation serological assay for monitoring HIV exposure

Also Published As

Publication number Publication date
US20020150883A1 (en) 2002-10-17
AU4662993A (en) 1994-01-31
PL174686B1 (en) 1998-08-31
DE69331845D1 (en) 2002-06-06
RU2126158C1 (en) 1999-02-10
ATE216779T1 (en) 2002-05-15
DK0649537T3 (en) 2002-06-17
JPH07509060A (en) 1995-10-05
UA39944C2 (en) 2001-07-16
SK284556B6 (en) 2005-06-02
EP0649537B2 (en) 2006-02-22
NO950006L (en) 1995-02-24
EP0649537B1 (en) 2002-04-24
ES2171414T3 (en) 2002-09-16
DK0649537T4 (en) 2006-04-10
PT649537E (en) 2002-09-30
AU685059B2 (en) 1998-01-15
NO321185B1 (en) 2006-04-03
JP3490085B2 (en) 2004-01-26
DE69331845T3 (en) 2006-10-05
WO1994001778A1 (en) 1994-01-20
JP2003329687A (en) 2003-11-19
RU94046284A (en) 1997-02-27
ES2171414T5 (en) 2006-09-01
CZ695A3 (en) 1996-03-13
HU9500008D0 (en) 1995-03-28
CZ291951B6 (en) 2003-06-18
FI950002L (en) 1995-02-27
FI110546B (en) 2003-02-14
EP0649537A1 (en) 1995-04-26
DE69331845T2 (en) 2002-08-14
PL307178A1 (en) 1995-05-02
CA2139645C (en) 2003-02-11
FI950002A0 (en) 1995-01-02
HUT70473A (en) 1995-10-30
CA2139645A1 (en) 1994-01-20
NO950006D0 (en) 1995-01-02

Similar Documents

Publication Publication Date Title
SK495A3 (en) Detection method of antibodies of hepatitis virus and set for detection of antibodies hcv
FI935808A0 (en) Hepatitis C virus (HCV) polypeptide
MY107499A (en) Combination of hepatitis c virus(hcv) antigens for use in immunoassays for anti-hcv antibodies.
EP1018558A3 (en) Hepatitis C Virus Epitopes
NZ219113A (en) Hiv peptide containing epitope of the env protein
GB2154609B (en) Hcmv monoclonal antibodies and their use in the detection of hcmv infection and hcmv specific igm, and methods of detecting viral antigens
CA2032907A1 (en) Hepatitis c assay
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
CA2049679A1 (en) Hepatitis c assay utilizing recombinant antigens
HK1013849A1 (en) An augmented western blot format and immunoassay for detection of viral antibodies
CA2111325A1 (en) Detection of mammalian immunodeficiency viruses
Meurman Detection of antiviral IgM antibodies and its problems—a review
EP0248534A3 (en) Method of detecting aids virus infection
CA2113383A1 (en) Immunometric determination of an antigen or hapten
EP0190972A3 (en) Non-a non-b hepatitis antigens
KR930008155A (en) Monoclonal Antibodies Against Hepatitis Hepatitis Virus (HCV)
KR890014729A (en) Methods for preparing monoclonal antibodies against non-A, non-hepatitis B infected livers
CA2080213A1 (en) Diagnostic reagent for hepatitis c
EP0293184A3 (en) Immunodiagnostic assays using chimeric antigens
Stevenson et al. The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM
SE9101863D0 (en) PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
WO2001009609A3 (en) Hepatitis c viral antigen immunoassay detection systems
CA2112667A1 (en) Monoclonal antibodies to putative hcv ns5 proteins and methods for using same
Morgan-Capner et al. Rubella.
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20130702